Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

Abstract

Ramipril significantly reduces the rates of death, myocardial infarction, and stroke in a broad range of high-risk patients who are not known to have a low ejection fraction or heart failure.

Keywords

RamiprilMedicineInternal medicinePlaceboMyocardial infarctionHeart failureEjection fractionACE inhibitorRelative riskStroke (engine)Angiotensin-converting enzymeCardiologyDiabetes mellitusConfidence intervalEndocrinologyBlood pressure

Affiliated Institutions

Related Publications

Captopril Treatment of Chronic Heart Failure in the Very Old

Veerle De Bock , Tony Mets , Marco Romagnoli +1 more

The study gives further evidence that angiotensin-converting enzyme inhibitor treatment for very old patients with chronic heart failure is useful.

1994 Journal of Gerontology 24 citations

Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials

Costas Thomopoulos , Gianfranco Parati , Alberto Zanchetti

Meta-analyses of all BP-lowering RCTs involving hypertensive patients provide precise estimates of benefits (larger for stroke and heart failure, but also significant for CHD an...

2014 Journal of Hypertension 364 citations

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Stephen D. Wiviott , Itamar Raz , Marc P. Bonaca +17 more

In patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease, treatment with dapagliflozin did not result in a higher or lower rate of MAC...

2018 New England Journal of Medicine 5890 citations

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

Carlos M. Ferrario , Jewell A. Jessup , Mark C. Chappell +5 more

Background— Angiotensin-converting enzyme 2 (ACE2) has emerged as a novel regulator of cardiac function and arterial pressure by converting angiotensin II (Ang II) into the vaso...

2005 Circulation 1598 citations

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

M R Law , Joan K. Morris , Nicholas Wald

With the exception of the extra protective effect of beta blockers given shortly after a myocardial infarction and the minor additional effect of calcium channel blockers in pre...

2009 BMJ 2727 citations

Publication Info

Year: 2000
Type: article
Volume: 342
Issue: 3
Pages: 145-153
Citations: 8597
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

8597

OpenAlex

Cite This

APA Style

                            
                                
                                    Salim Yusuf, 
                                
                                    Peter Sleight, 
                                
                                    Janice Pogue
                                
                                et al.
                            
                            (2000). 
                            Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients. 
                            New England Journal of Medicine
                            , 342
                            (3)
                            , 145-153.
                            https://doi.org/10.1056/nejm200001203420301
                        

Identifiers

DOI: 10.1056/nejm200001203420301